Am J Psychiatry 159:655-657, April 2002
© 2002 American Psychiatric Association
Metformin for Weight Loss in Pediatric Patients Taking Psychotropic Drugs
John A. Morrison, Ph.D.,
Elizabeth M. Cottingham, M.D., and
Bruce A. Barton, Ph.D.
OBJECTIVE: Metformin was assessed as a treatment for weight gain in children taking olanzapine, risperidone, quetiapine, or valproate. METHOD: The subjects were 19 patients aged 10–18 years; 15 were white and four were black, and there were 12 boys and seven girls. In a 12-week open-label study, each patient received metformin, 500 mg t.i.d. Changes in weight and body mass index were evaluated by using repeated measures analysis of variance. RESULTS: Of the 19 patients, 15 lost weight, three gained 1.6 kg or less, and one had no change. The mean changes in weight and body mass index at 12 weeks were highly significant. CONCLUSIONS: Metformin merits further study as a treatment for weight gain in patients taking psychotropic medications.
This article has been cited by other articles:
|
|
|
|
 
R.-R. Wu, J.-P. Zhao, H. Jin, P. Shao, M.-S. Fang, X.-F. Guo, Y.-Q. He, Y.-J. Liu, J.-D. Chen, and L.-H. Li
Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain: A Randomized Controlled Trial
JAMA,
January 9, 2008;
299(2):
185 - 193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Towbin
Gaining: Pediatric Patients and Use of Atypical Antipsychotics
Am J Psychiatry,
December 1, 2006;
163(12):
2034 - 2036.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Klein, E. M. Cottingham, M. Sorter, B. A. Barton, and J. A. Morrison
A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated With Initiation of Atypical Antipsychotic Therapy in Children and Adolescents
Am J Psychiatry,
December 1, 2006;
163(12):
2072 - 2079.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Robinson, M. G. Woerner, B. Napolitano, R. C. Patel, S. M. Sevy, H. Gunduz-Bruce, J. M. Soto-Perello, A. Mendelowitz, A. Khadivi, R. Miller, et al.
Randomized Comparison of Olanzapine Versus Risperidone for the Treatment of First-Episode Schizophrenia: 4-Month Outcomes
Am J Psychiatry,
December 1, 2006;
163(12):
2096 - 2102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Srinivasan, G. R. Ambler, L. A. Baur, S. P. Garnett, M. Tepsa, F. Yap, G. M. Ward, and C. T. Cowell
Randomized, Controlled Trial of Metformin for Obesity and Insulin Resistance in Children and Adolescents: Improvement in Body Composition and Fasting Insulin
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2074 - 2080.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G Robinson, M. G Woerner, H. M Delman, and J. M Kane
Pharmacological Treatments for First-Episode Schizophrenia
Schizophr Bull,
July 1, 2005;
31(3):
705 - 722.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E K. Hester and M. R Thrower
Current Options in the Management of Olanzapine-Associated Weight Gain
Ann. Pharmacother.,
February 1, 2005;
39(2):
302 - 310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Zametkin, C. K. Zoon, H. W. Klein, and S. Munson
Psychiatric Aspects of Child and Adolescent Obesity: A Review of the Past 10 Years
Focus,
October 1, 2004;
2(4):
625 - 641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ten and N. Maclaren
Insulin Resistance Syndrome in Children
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2526 - 2539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Rasgon and L. Jarvik
Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis
J. Gerontol. A Biol. Sci. Med. Sci.,
February 1, 2004;
59(2):
M178 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Metformin for Children Taking Psychotropic Medications
Journal Watch Psychiatry,
May 23, 2002;
2002(523):
2 - 2.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
